ArticleWorld journal of nephrology2026

From kidney to liver: Are sodium-glucose cotransporter-2 inhibitors emerging as metabolic disease modifiers?

Sydney Mpisa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.